Compare NBTX & XNDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | XNDU |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2018 | 2025 |
| Metric | NBTX | XNDU |
|---|---|---|
| Price | $29.31 | $2.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $54.00 | $28.75 |
| AVG Volume (30 Days) | 137.8K | ★ 7.2M |
| Earning Date | 09-24-2026 | 11-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $100.08 |
| Revenue Next Year | $50.69 | $22.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.78 | $2.65 |
| 52 Week High | $57.14 | $42.44 |
| Indicator | NBTX | XNDU |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 19.71 |
| Support Level | $20.18 | N/A |
| Resistance Level | $35.38 | $5.32 |
| Average True Range (ATR) | 1.55 | 0.34 |
| MACD | 0.84 | 0.07 |
| Stochastic Oscillator | 92.73 | 2.06 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Xanadu Quantum Technologies Ltd specializes in designing photonic devices and the platforms around them, including the experimentation and development of quantum computers available on the cloud with supporting software, along with quantum simulators and other related products and offerings. Its products include: Aurora, PennyLane, Catalyst, Lightning, Catalyst and PennyLane Codebook. The company operates in industries such as automotive, aerospace, energy, materials, and semiconductor sectors.